- Home
- KIRK vs MIRA Comparison
KIRK vs MIRA Comparison
Compare KIRK & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIRK
- MIRA
- Stock Information
- Founded
- KIRK 1966
- MIRA 2020
- Country
- KIRK United States
- MIRA United States
- Employees
- KIRK N/A
- MIRA N/A
- Industry
- KIRK Diversified Commercial Services
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- KIRK Miscellaneous
- MIRA Health Care
- Exchange
- KIRK Nasdaq
- MIRA Nasdaq
- Market Cap
- KIRK 20.2M
- MIRA 20.5M
- IPO Year
- KIRK 2002
- MIRA 2023
- Fundamental
- Price
- KIRK $1.31
- MIRA $0.95
- Analyst Decision
- KIRK Buy
- MIRA Strong Buy
- Analyst Count
- KIRK 2
- MIRA 2
- Target Price
- KIRK $4.50
- MIRA $14.00
- AVG Volume (30 Days)
- KIRK 118.2K
- MIRA 360.9K
- Earning Date
- KIRK 04-08-2025
- MIRA 05-12-2025
- Dividend Yield
- KIRK N/A
- MIRA N/A
- EPS Growth
- KIRK N/A
- MIRA N/A
- EPS
- KIRK N/A
- MIRA N/A
- Revenue
- KIRK $458,411,000.00
- MIRA N/A
- Revenue This Year
- KIRK N/A
- MIRA N/A
- Revenue Next Year
- KIRK $0.37
- MIRA N/A
- P/E Ratio
- KIRK N/A
- MIRA N/A
- Revenue Growth
- KIRK N/A
- MIRA N/A
- 52 Week Low
- KIRK $1.10
- MIRA $0.51
- 52 Week High
- KIRK $2.57
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- KIRK 46.79
- MIRA 38.16
- Support Level
- KIRK $1.22
- MIRA $1.06
- Resistance Level
- KIRK $1.40
- MIRA $1.29
- Average True Range (ATR)
- KIRK 0.08
- MIRA 0.11
- MACD
- KIRK 0.01
- MIRA -0.02
- Stochastic Oscillator
- KIRK 45.00
- MIRA 4.74
About KIRK Kirkland's Inc. COMMONSTOCK
Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.